We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.14B
AUM Growth
+$178M
Cap. Flow
-$28.9M
Cap. Flow %
-0.92%
Top 10 Hldgs %
27.66%
Holding
502
New
39
Increased
154
Reduced
177
Closed
19

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.91M
2
AAPL icon
Apple
AAPL
+$5.57M
3
NOW icon
ServiceNow
NOW
+$4.84M
4
SBAC icon
SBA Communications
SBAC
+$1.43M
5
CVX icon
Chevron
CVX
+$863K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.9M
2
OXY icon
Occidental Petroleum
OXY
+$7.57M
3
FAST icon
Fastenal
FAST
+$4.54M
4
IBM icon
IBM
IBM
+$3.34M
5
MSFT icon
Microsoft
MSFT
+$2.82M

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Healthcare 15.32%
3 Financials 13.99%
4 Industrials 9.68%
5 Consumer Staples 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
226
Vanguard Dividend Appreciation ETF
VIG
$113B
$726K 0.02%
5,826
+888
+18% +$107K
OLED icon
227
Universal Display
OLED
$3.85B
$721K 0.02%
+3,500
New +$661K
VRTX icon
228
Vertex Pharmaceuticals
VRTX
$124B
$718K 0.02%
3,278
-74
-2% -$15K
SCHF icon
229
Schwab International Equity ETF
SCHF
$65.5B
$716K 0.02%
42,584
+4,882
+13% +$80.3K
TIP icon
230
iShares TIPS Bond ETF
TIP
$14.5B
$711K 0.02%
6,102
+546
+10% +$63.5K
CABO icon
231
Cable One
CABO
$249M
$707K 0.02%
475
CAH icon
232
Cardinal Health
CAH
$54.5B
$690K 0.02%
13,636
+350
+3% +$18.1K
ELV icon
233
Elevance Health
ELV
$83.7B
$688K 0.02%
2,278
+203
+10% +$55.9K
ENB icon
234
Enbridge
ENB
$121B
$677K 0.02%
17,020
-358
-2% -$13.4K
VNQ icon
235
Vanguard Real Estate ETF
VNQ
$40B
$665K 0.02%
7,171
+975
+16% +$90.3K
MMP
236
DELISTED
Magellan Midstream Partners, L.P.
MMP
$645K 0.02%
10,266
+153
+2% +$9.53K
CLX icon
237
Clorox
CLX
$12.1B
$644K 0.02%
4,196
-333
-7% -$49.8K
TPL icon
238
Texas Pacific Land
TPL
$26.9B
$641K 0.02%
7,389
SCHB icon
239
Schwab US Broad Market ETF
SCHB
$42.9B
$640K 0.02%
49,956
-402
-0.8% -$4.93K
LNT icon
240
Alliant Energy
LNT
$19.1B
$634K 0.02%
11,580
AMP icon
241
Ameriprise Financial
AMP
$48.3B
$618K 0.02%
3,708
-186
-5% -$28.8K
OXY icon
242
Occidental Petroleum
OXY
$53.6B
$611K 0.02%
14,822
-188,952
-93% -$7.57M
EOG icon
243
EOG Resources
EOG
$74.4B
$588K 0.02%
7,025
-1,275
-15% -$93.4K
BX icon
244
Blackstone
BX
$107B
$572K 0.02%
10,231
-1,019
-9% -$52.9K
ACWI icon
245
iShares MSCI ACWI ETF
ACWI
$32.5B
$567K 0.02%
7,150
-40
-0.6% -$3.06K
EW icon
246
Edwards Lifesciences
EW
$48.2B
$567K 0.02%
7,296
-231
-3% -$18K
LFUS icon
247
Littelfuse
LFUS
$9.91B
$558K 0.02%
2,916
+660
+29% +$121K
RBC icon
248
RBC Bearings
RBC
$18.2B
$557K 0.02%
3,520
GD icon
249
General Dynamics
GD
$106B
$556K 0.02%
3,150
EWC icon
250
iShares MSCI Canada ETF
EWC
$6.18B
$546K 0.02%
18,263
-100
-0.5% -$2.92K

Similar funds

Gofen & Glossberg's Q4 2019 Portfolio in Review

As of Q4 2019, Gofen & Glossberg held 502 positions worth $3.14B, up 6% from $2.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gofen & Glossberg's Q4 2019 filing shows 39 new, 154 increased, 177 reduced and 19 closed positions. Its largest new stake was SBA Communications: 6,040 shares worth $1.46M. The largest sale was Celgene Corp, an estimated $14.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2019 buy was SBA Communications: 6,040 shares worth $1.46M.
  • Gofen & Glossberg added most to Bristol-Myers Squibb in Q4 2019, an estimated $7.91M increase.
  • Gofen & Glossberg's biggest Q4 2019 reduction was Occidental Petroleum, cutting an estimated $7.57M.
  • Gofen & Glossberg fully exited Celgene Corp in Q4 2019, selling an estimated $14.9M.
  • Gofen & Glossberg's ten largest holdings make up 28% of its $3.14B portfolio in Q4 2019.
  • Gofen & Glossberg opened 39 new positions and closed 19 in Q4 2019.
  • Gofen & Glossberg's portfolio value rose 6% quarter-over-quarter to $3.14B.

Based on Gofen & Glossberg's 13F filing for Q4 2019, filed 28 Jan 2020.